The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Novel cannabinoid receptors
Open accessAbstract
Cannabinoids have numerous physiological effects. In the years since the molecular identification of the G protein‐coupled receptors CB 1 and CB 2, the ion channel TRPV 1, and their corresponding endogenous ligand systems, many cannabinoid‐evoked actions have been shown conclusively to be mediated by one of these specific receptor targets. However, there remain several examples where these classical cannabinoid receptors do not explain observed pharmacology. Studies using mice genetically deleted for the known receptors have confirmed the existence of additional targets, which have come to be known collectively as non‐CB 1/CB 2 receptors. Despite intense research efforts, the molecular identity of these non‐CB 1/CB 2 receptors remains for the most part unclear. Two orphan G protein‐coupled receptors have recently been implicated as novel cannabinoid receptors; these are GPR119, which has been proposed as a receptor for oleoylethanolamide, and GPR55 which has been proposed as a receptor activated by multiple different cannabinoid ligands. In this review I will present an introduction to non‐CB 1/CB 2 pharmacology, summarize information on GPR55 and GPR119 currently available, and consider their phylogenetic origin and what aspects of non‐CB 1/CB 2 pharmacology, if any, they help explain. British Journal of Pharmacology (2007) 152, 567–575; doi:10.1038/sj.bjp.0707481; published online 1 October 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Lysophosphatidylcholine as a Ligand for the Immunoregulatory Receptor G2A
Kabarowski, J. H. S., Zhu, K., Le, L. Q., Witte, O. N., & Xu, Y. (2001) · Science · doi:10.1126/science.1061781 · Cited by 332
RetractedWitte, O. N., Kabarowski, J. H. S., Xu, Y., Le, L. Q., & Zhu, K. (2005) · Science · doi:10.1126/science.307.5707.206b · Cited by 55
RetractedThe Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.255 · Cited by 1,099
Fu, J., Gaetani, S., Oveisi, F., Lo Verme, J., Serrano, A., Rodríguez de Fonseca, F., Rosengarth, A., Luecke, H., Di Giacomo, B., Tarzia, G., et al. (2003) · Nature · doi:10.1038/nature01921 · Cited by 1,064
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,064
Control of pain initiation by endogenous cannabinoids
Calignano, A., Rana, G. L., Giuffrida, A., & Piomelli, D. (1998) · Nature · doi:10.1038/28393 · Cited by 1,056
Chinetti, G., Fruchart, J.-C., & Staels, B. (2000) · Inflammation Research · doi:10.1007/s000110050622 · Cited by 954
Lo Verme, J., Fu, J., Astarita, G., La Rana, G., Russo, R., Calignano, A., & Piomelli, D. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006353 · Cited by 882
Cannabinoid-based drugs as anti-inflammatory therapeutics
Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728
An anorexic lipid mediator regulated by feeding
Rodríguez de Fonseca, F., Navarro, M., Gómez, R., Escuredo, L., Nava, F., Fu, J., Murillo-Rodríguez, E., Giuffrida, A., LoVerme, J., Gaetani, S., et al. (2001) · Nature · doi:10.1038/35102582 · Cited by 694
Kynurenic Acid as a Ligand for Orphan G Protein-coupled Receptor GPR35
Wang, J., Simonavicius, N., Wu, X., Swaminath, G., Reagan, J., Tian, H., & Ling, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603503200 · Cited by 687
Overton, H. A., Babbs, A. J., Doel, S. M., Fyfe, M. C. T., Gardner, L. S., Griffin, G., Jackson, H. C., Procter, M. J., Rasamison, C. M., Tang-Christensen, M., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.004 · Cited by 655
Járai, Z., Wagner, J. A., Varga, K., Lake, K. D., Compton, D. R., Martin, B. R., Zimmer, A. M., Bonner, T. I., Buckley, N. E., Mezey, E., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14136 · Cited by 599
Noguchi, K., Ishii, S., & Shimizu, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302648200 · Cited by 557
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor
Buckley, N. E., McCoy, K. L., Mezey, É., Bonner, T., Zimmer, A., Felder, C. C., Glass, M., & Zimmer, A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00211-9 · Cited by 544
Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain
Breivogel, C. S., Griffin, G., Di Marzo, V., & Martin, B. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.155 · Cited by 541
Cannabidiol: An Overview of Some Pharmacological Aspects
Mechoulam, R., Parker, L. A., & Gallily, R. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb05998.x · Cited by 508
Ibrahim, M. M., Deng, H., Zvonok, A., Cockayne, D. A., Kwan, J., Mata, H. P., Vanderah, T. W., Lai, J., Porreca, F., Makriyannis, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834309100 · Cited by 491
GPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA5
Lee, C.-W., Rivera, R., Gardell, S., Dubin, A. E., & Chun, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603670200 · Cited by 471
Hájos, N., Ledent, C., & Freund, T. F. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00287-1 · Cited by 419
Evidence for novel cannabinoid receptors
BEGG, M., PACHER, P., BATKAI, S., OSEIHYIAMAN, D., OFFERTALER, L., MO, F., LIU, J., & KUNOS, G. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.11.005 · Cited by 385
Biochemistry and pharmacology of endovanilloids
Starowicz, K., Nigam, S., & Di Marzo, V. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.01.005 · Cited by 383
Soga, T., Ohishi, T., Matsui, T., Saito, T., Matsumoto, M., Takasaki, J., Matsumoto, S.-I., Kamohara, M., Hiyama, H., Yoshida, S., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.120 · Cited by 367
Jaggar, S. I., Hasnie, F. S., Sellaturay, S., & Rice, A. S. C. (1998) · Pain · doi:10.1016/s0304-3959(98)00041-4 · Cited by 354
In silico patent searching reveals a new cannabinoid receptor
Baker, D., Pryce, G., Davies, W. L., & Hiley, C. R. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.003 · Cited by 348
Seven evolutionarily conserved human rhodopsin G protein‐coupled receptors lacking close relatives
Fredriksson, R., Höglund, P. J., Gloriam, D. E. I., Lagerström, M. C., & Schiöth, H. B. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01196-7 · Cited by 292
Cannabinoid receptors and endocannabinoids: Evidence for new players
Mackie, K., & Stella, N. (2006) · The AAPS Journal · doi:10.1007/bf02854900 · Cited by 275
The search for the palmitoylethanolamide receptor
LoVerme, J., La Rana, G., Russo, R., Calignano, A., & Piomelli, D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.012 · Cited by 248
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain
Clayton, N., Marshall, F. H., Bountra, C., & O'Shaughnessy, C. T. (2002) · Pain · doi:10.1016/s0304-3959(01)00454-7 · Cited by 247
Food Intake Regulates Oleoylethanolamide Formation and Degradation in the Proximal Small Intestine
Fu, J., Astarita, G., Gaetani, S., Kim, J., Cravatt, B. F., Mackie, K., & Piomelli, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607809200 · Cited by 244
Johns, D. G., Behm, D. J., Walker, D. J., Ao, Z., Shapland, E. M., Daniels, D. A., Riddick, M., Dowell, S., Staton, P. C., Green, P., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707419 · Cited by 242
Self-citationHaller, J., Varga, B., Ledent, C., & Freund, T. F. (2004) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000135704.56422.40 · Cited by 241 · cited 1×
“Hints about the role of hippocampal non-CB1/CB2 receptors have come from the demonstration that SR141716A but not AM251 has anxiolytic effects in CB1 / mice, hence the non-CB1/CB2 site might mediate anxiogenesis, opposing the anxiolytic effects of CB1 (Haller et al., 2004).”
BackgroundCannabinoid receptors in microglia of the central nervous system: immune functional relevance
Cabral, G. A., & Marciano-Cabral, F. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405216 · Cited by 240
Selective Ligands and Cellular Effectors of a G Protein-Coupled Endothelial Cannabinoid Receptor
Offertáler, L., Mo, F.-M., Bátkai, S., Liu, J., Begg, M., Razdan, R. K., Martin, B. R., Bukoski, R. D., & Kunos, G. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.3.699 · Cited by 228
Sawzdargo, M., George, S. R., Nguyen, T., Xu, S., Kolakowski, L. F., & O'dowd, B. F. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7513 · Cited by 207
Obinata, H., Hattori, T., Nakane, S., Tatei, K., & Izumi, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507787200 · Cited by 183
PPARs: Transcription Factors Controlling Lipid and Lipoprotein Metabolism
BOCHER, V., PINEDA‐TORRA, I., FRUCHART, J., & STAELS, B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04258.x · Cited by 178
Receptors coupled to heterotrimeric G proteins of the G12 family
Riobo, N. A., & Manning, D. R. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.01.007 · Cited by 176
Evolutionary origins of the endocannabinoid system
McPartland, J. M., Matias, I., Di Marzo, V., & Glass, M. (2006) · Gene · doi:10.1016/j.gene.2005.11.004 · Cited by 176
Rockwell, C. E., Snider, N. T., Thompson, J. T., Vanden Heuvel, J. P., & Kaminski, N. E. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.019117 · Cited by 176
Brown, A. J., Dyos, S. L., Whiteway, M. S., White, J. H. M., Watson, M.-A. E. A., Marzioch, M., Clare, J. J., Cousens, D. J., Paddon, C., Plumpton, C., et al. (2000) · Yeast · doi:10.1002/(sici)1097-0061(20000115)16:1<11::aid-yea502>3.0.co;2-k · Cited by 173
Self-citationElmes, S. J. R., Jhaveri, M. D., Smart, D., Kendall, D. A., & Chapman, V. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03690.x · Cited by 160
Taniguchi, Y., Tonai‐Kachi, H., & Shinjo, K. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.08.015 · Cited by 157
Cannabinoid Receptors and Endocannabinoids: Evidence for New Players
Mackie, K., & Stella, N. (2006) · The AAPS Journal · doi:10.1208/aapsj080234 · Cited by 149
Giblin, G. M. P., O’Shaughnessy, C. T., Naylor, A., Mitchell, W. L., Eatherton, A. J., Slingsby, B. P., Rawlings, D. A., Goldsmith, P., Brown, A. J., Haslam, C. P., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061195+ · Cited by 129
Self-citationHypertension and RhoA/Rho-Kinase Signaling in the Vasculature
Lee, D. L., Webb, R. C., & Jin, L. (2004) · Hypertension · doi:10.1161/01.hyp.0000148303.98066.ab · Cited by 125
Targeting cannabinoid agonists for inflammatory and neuropathic pain
Cheng, Y., & Hitchcock, S. A. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.7.951 · Cited by 111
Food intake is inhibited by oral oleoylethanolamide
Nielsen, M. J., Petersen, G. L., Astrup, A. V., & Hansen, H. S. (2004) · Journal of Lipid Research · doi:10.1194/jlr.c300008-jlr200 · Cited by 103
Yeast Assays for G-Protein-Coupled Receptors
Dowell, S. J., & Brown, A. J. (2002) · Receptors and Channels · doi:10.3109/10606820214647 · Cited by 102
Self-citationCannabinoids, Immune System and Cytokine Network
Massi, P., Vaccani, A., & Parolaro, D. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777947425 · Cited by 101
Sakamoto, Y., Inoue, H., Kawakami, S., Miyawaki, K., Miyamoto, T., Mizuta, K., & Itakura, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.076 · Cited by 101
Formation of B and T cell subsets require the cannabinoid receptor CB2
Ziring, D., Wei, B., Velázquez, P., Schrage, M. I., Buckley, N. E., & Braun, J. G. (2006) · Immunogenetics · doi:10.1007/s00251-006-0138-x · Cited by 98
Fujiwara, Y., Sardar, V. M., Tokumura, A., Baker, D. L., Murakami‐Murofushi, K., Parrill, A. L., & Tigyi, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504351200 · Cited by 87
Begg, M., Mo, F.-M., Offertáler, L., Bátkai, S., Pacher, P., Razdan, R. K., Lovinger, D. M., & Kunos, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307258200 · Cited by 85
Yeast Assays for G-Protein-Coupled Receptors
Dowell, S. J., & Brown, A. J. (2002) · Receptors and Channels · doi:10.1080/10606820214647 · Cited by 71
Self-citationRusso, R., LoVerme, J., Rana, G. L., D’Agostino, G., Sasso, O., Calignano, A., & Piomelli, D. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.03.007 · Cited by 55
O’Sullivan, S. E., Kendall, D. A., & Randall, M. D. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706218 · Cited by 54
GPR55 and the vascular receptors for cannabinoids
Hiley, C. R., & Kaup, S. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707421 · Cited by 44
Cannabinoid-Mediated Elevation of Intracellular Calcium: A Structure-Activity Relationship
Rao, G. K., & Kaminski, N. E. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.100503 · Cited by 40
Kraft, B., Wintersberger, W., & Kress, H. G. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.02.007 · Cited by 32
Cited by
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529
Cannabidiol: State of the art and new challenges for therapeutic applications
Pisanti, S., Malfitano, A. M., Ciaglia, E., Lamberti, A., Ranieri, R., Cuomo, G., Abate, M., Faggiana, G., Proto, M. C., Fiore, D., et al. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.041 · Cited by 614
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Zhang, M., Chen, T., Lu, X., Lan, X., Chen, Z., & Lu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01803-6 · Cited by 491
Cannabinoids and the gut: New developments and emerging concepts
Izzo, A. A., & Sharkey, K. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.12.005 · Cited by 419
The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo
Whyte, L. S., Ryberg, E., Sims, N. A., Ridge, S. A., Mackie, K., Greasley, P. J., Ross, R. A., & Rogers, M. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902743106 · Cited by 330
Metadata
- Authors
- Brown, A. J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2007-11
- Volume
- 152
- Issue
- 5
- Pages
- 567-575
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1824285398
- Cited by
- 409
- References
- 61
- FWCI
- 25.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.